Trials / Withdrawn
WithdrawnNCT02027246
Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury
Autologous Bone Marrow Mononuclear Cell Therapy for Spinal Cord Injury
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 8 Months – 63 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.
Detailed description
Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by standard rehabilitation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous bone marrow mononuclear cell transplantation | Bone marrow is aspirated by a standard procedure. Mononuclear cells are separated by density gradient method and then injected intrathecally by a standard lumbar puncture procedure |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2012-08-01
- Completion
- 2013-02-01
- First posted
- 2014-01-06
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02027246. Inclusion in this directory is not an endorsement.